ECO Animal Health Group (LON:EAH) Rating Reiterated by Shore Capital

ECO Animal Health Group (LON:EAH)‘s stock had its “buy” rating reissued by research analysts at Shore Capital in a report issued on Tuesday, LSE.Co.UK reports.

ECO Animal Health Group Stock Up 2.0 %

Shares of LON EAH opened at GBX 108.45 ($1.43) on Tuesday. ECO Animal Health Group has a 52-week low of GBX 82.67 ($1.09) and a 52-week high of GBX 135 ($1.78). The company has a debt-to-equity ratio of 4.31, a quick ratio of 2.14 and a current ratio of 2.96. The company’s 50 day moving average price is GBX 114.23 and its 200-day moving average price is GBX 107.56. The company has a market capitalization of £73.46 million, a P/E ratio of 5,422.50 and a beta of -0.05.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.